Cargando…
Melanoma Inhibitory Activity and regional lymph node status in malignant melanoma patients
Autores principales: | Sandru, Angela, Voinea, Silviu, Panaitescu, Eugenia, Bolovan, Madalina, Stanciu, Adina, Cinca, Sabin, Blidaru, Alexandru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315276/ http://dx.doi.org/10.1186/1479-5876-13-S1-P11 |
Ejemplares similares
-
Clinical value of Melanoma Inhibitory Activity in stratifying malignant melanoma patients
por: Sandru, Angela, et al.
Publicado: (2015) -
Prognostic Value of Melanoma Inhibitory Activity Protein in Localized Cutaneous Malignant Melanoma
por: Sandru, Angela, et al.
Publicado: (2014) -
Simultaneous determination of two serum tumor markers in assessing malignant melanoma patients
por: Sandru, Angela, et al.
Publicado: (2015) -
Survival rates of patients with metastatic malignant melanoma
por: Sandru, A, et al.
Publicado: (2014) -
Impact of gender and primary tumor location on outcome of patients with cutaneous melanoma
por: Voinea, S, et al.
Publicado: (2016)